NCT01654926View on ClinicalTrials.gov

Feasibility Assessment of the Aquadex FlexFlowTM Ultrafiltration System in Treating Non Hospitalized Heart Failure Patients in Dedicated Heart Failure Centers

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Heart Failure
Interventions
PROCEDURE

blood ultrafiltration

Trial Locations (1)

Unknown

Lin Clinic, Haifa

Sponsors
All Listed Sponsors
lead

Clalit Health Services

OTHER

NCT01654926 - Feasibility Assessment of the Aquadex FlexFlowTM Ultrafiltration System in Treating Non Hospitalized Heart Failure Patients in Dedicated Heart Failure Centers | Biotech Hunter | Biotech Hunter